Back to Research Vault

Saham Boost

Life Insurance - 25 June 2019

Ingham Analytics succinctly sets out the pros and cons of being invested in Sanlam. A positive to earnings this financial year is the acquisition of the remaining 53.7% of Saham whilst agreements concluded with Capitec in 2018 will further assist volumes. By investing in Sanlam, investors gain indirect exposure to Santam, the largest short-term insurer in South Africa. Ingham Analytics have updated their earnings estimates and suggested target price. Purchase the Ingham Analytics Sanlam note and the insightful analysis of the investment opportunity and risks.

Trader: R15.00

Add to cart